Atreon Orthopedics® is developing a line of scaffold-based orthopedic products that accelerate and improve the quality of repair at the site of a soft tissue injury. The first product, The Attreon BTi, is planned to launch in 2018.
The Atreon BTi is completely resorbable. Over the course of 3 months, the product is completely gone, leaving behind healthy tissue.
This video shows cells migrating along the scaffold material just as they would in the body. An in-vitro study against a prominent competitor showed that the Atreon BTi outperformed in cell proliferation and adhesion.
The Atreon BTi mimics the extracellular matrix found naturally in the body. Our scaffold is engineered to promote healthy tissue growth rather than an inflammatory response - thus decreasing scar tissue formation.